Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
NCT01863914
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
End-stage Kidney Disease
Diabetes Mellitus
Arteriovenous Fistula
Interventions
DRUG:
Rosuvastatin
Sponsor
National Cheng-Kung University Hospital